Track the Organigram Global Inc. stock price and the full insider trade history of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the oversight of SEDI. Market capitalisation: €236.9m. The latest transaction was filed on 27 August 2026 (00 - Opening Balance-Initial SEDI Report). Among the most active insiders: Hansel, Finn A.. The full history is free.
Analysts rate Organigram Global Inc. Buy (bullish), based on 5 analysts. Average price target: CA$3.12.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Organigram Global Inc. is a Canadian company focused on cannabis production. It is listed on the Toronto Stock Exchange under the symbol XTSE.